Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT

Detalles Bibliográficos
Autores principales: Hill, Richard, Madureira, Patricia A., Ferreira, Bibiana, Baptista, Inês, Machado, Susana, Colaҫo, Laura, dos Santos, Marta, Liu, Ningshu, Dopazo, Ana, Ugurel, Selma, Adrienn, Angyal, Kiss-Toth, Endre, Isbilen, Murat, Gure, Ali O., Link, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356827/
https://www.ncbi.nlm.nih.gov/pubmed/37468494
http://dx.doi.org/10.1038/s41467-023-40050-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356827/
https://www.ncbi.nlm.nih.gov/pubmed/37468494
http://dx.doi.org/10.1038/s41467-023-40050-1

Ejemplares similares